Status:
UNKNOWN
Patients Without Standard Modifiable Cardiovascular Risk Factors (SMuRF-less) and Their Prognosis After a ST-segment-Elevation Myocardial Infarction (STEMI)
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
STEMI
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to asses the prognosis of STEMI patients without standard modifiable risk factors of cardiovascular disease (diabetes mellitus, hyperlipidemia, hypertension and cigarette ...
Eligibility Criteria
Inclusion
- STEMI patients who had a percutaneous coronary intervention (PCI) in our PCI center.
Exclusion
- Pain duration exceeding 24h. Perioperative STEMI, including STEMI related to cardiac surgery.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05321667
Start Date
April 1 2022
End Date
August 31 2022
Last Update
April 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut du Coeur et des Vaisseaux Louis Mathieu
Vandœuvre-lès-Nancy, Meurthe-et-Moselle, France, 54500